TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
35.07
+0.52 (1.51%)
At close: Nov 22, 2024, 4:00 PM
35.23
+0.16 (0.46%)
After-hours: Nov 22, 2024, 6:59 PM EST
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $5.03 billion as of November 22, 2024. Its market cap has increased by 206.94% in one year.
Market Cap
5.03B
Enterprise Value
4.95B
1-Year Change
206.94%
Ranking
Category
Stock Price
$35.07
Market Cap Chart
Since May 3, 2010, TG Therapeutics's market cap has increased from $9.10M to $5.03B, an increase of 55,210.14%. That is a compound annual growth rate of 54.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 4.85B | 87.50% |
| Dec 29, 2023 | 2.59B | 50.41% |
| Dec 30, 2022 | 1.72B | -36.69% |
| Dec 31, 2021 | 2.72B | -60.29% |
| Dec 31, 2020 | 6.84B | 518.96% |
| Dec 31, 2019 | 1.11B | 225.13% |
| Dec 31, 2018 | 339.90M | -41.33% |
| Dec 29, 2017 | 579.30M | 127.62% |
| Dec 30, 2016 | 254.50M | -59.38% |
| Dec 31, 2015 | 626.60M | -10.02% |
| Dec 31, 2014 | 696.40M | 433.23% |
| Dec 31, 2013 | 130.60M | 43.20% |
| Dec 31, 2012 | 91.20M | 91,100.00% |
| Dec 30, 2011 | 100.00K | -97.92% |
| Dec 31, 2010 | 4.80M | -47.25% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 4.74B |
| Arcellx | 4.72B |
| Axsome Therapeutics | 4.58B |
| Alkermes | 4.52B |
| Integer Holdings | 4.47B |
| BridgeBio Pharma | 4.35B |
| Ultragenyx Pharmaceutical | 4.28B |
| Haemonetics | 4.27B |